![Howard Moore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Howard Moore
Vorsitzender bei NZeno Ltd.
Aktive Positionen von Howard Moore
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pictor Ltd.
![]() Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Geschäftsführer | 10.08.2020 | - |
Vorstandsvorsitzender | - | 10.08.2020 | |
NZeno Ltd.
![]() NZeno Ltd. Medical/Nursing ServicesHealth Services NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand. | Vorsitzender | 01.01.2020 | - |
Cure Kids Ventures Ltd.
![]() Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures Ltd (Cure Kids Ventures) is a venture capital subsidiary of Cure Kids founded in 2007. The firm is headquartered in Auckland, New Zealand. | Direktor/Vorstandsmitglied | 01.01.2008 | - |
Karriereverlauf von Howard Moore
Ehemalige bekannte Positionen von Howard Moore
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Gründer | 01.03.2004 | 01.03.2004 |
Corporate Officer/Principal | 01.03.2004 | 01.03.2004 |
Ausbildung von Howard Moore
Massey University | Undergraduate Degree |
Statistik
International
Neuseeland | 5 |
Vereinigte Staaten | 2 |
Operativ
Founder | 1 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Pictor Ltd.
![]() Pictor Ltd. BiotechnologyHealth Technology Pictor Ltd. operates as a biotechnology company. It develops technology for multiplexed testing for blood and biological fluids. The firm?s products include PictArrayTM ToRCH ELISA, ENA ELISA, and HAE ELISA Kit. The company was founded by Krishnanand Kumble and Sarita Kumble in 2005 and is headquartered in Auckland, New Zealand. | Health Technology |
NZeno Ltd.
![]() NZeno Ltd. Medical/Nursing ServicesHealth Services NZeno Ltd. produces safe pig kidneys that are compatible for human transplantation. The company was founded by Robert Bartlett Elliot, Olga Garkavenko and Paul Tan and is headquartered in Parnell, New Zealand. | Health Services |
Cure Kids Ventures Ltd.
![]() Cure Kids Ventures Ltd. Investment ManagersFinance Cure Kids Ventures Ltd (Cure Kids Ventures) is a venture capital subsidiary of Cure Kids founded in 2007. The firm is headquartered in Auckland, New Zealand. | Finance |
- Börse
- Insiders
- Howard Moore
- Erfahrung